SCHEMBL6640591

SCHEMBL6640591

O=C1Nc2ccc(F)cc2C2CCCC12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.44
NOS1 P29475 2/20 0.44
NOS2 P35228 2/20 0.44
HTR7 P34969 4/20 0.41
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR6 P50406 1/20 0.39
TP53 P04637 1/20 0.39
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
LRRK2 Q5S007 1/20 0.38
KMT2A Q03164 6/20 0.37
MEN1 O00255 3/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.36
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645276 0.87 NOS3 (0.44) NOS3NOS1NOS2HTR7ABCC8
SCHEMBL6137367 0.81 SIRT2 (0.50) NOS3NOS1NOS2HTR2CTP53
SCHEMBL6645803 0.81 NOS3 (0.44) NOS3NOS1NOS2TP53LRRK2
SCHEMBL6642314 0.81 NOS3 (0.44) NOS3NOS1NOS2HTR7HTR2C
SCHEMBL28979237 0.81 MAOA (0.38) CYP1A2MAPT
SCHEMBL6069995 0.81 NOS3 (0.45) NOS3NOS1NOS2TP53LRRK2
SCHEMBL6644248 0.80 KMT2A (0.50) NOS3NOS1NOS2KMT2AMEN1
SCHEMBL6642813 0.77 NOS3 (0.48) NOS3NOS1NOS2TP53ABCC8
SCHEMBL6641768 0.77 GSK3B (0.48) NOS3NOS1NOS2LRRK2MAPT
SCHEMBL4763337 0.76 IDO1 (0.45) NOS3NOS1NOS2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed
EP-1054869-A1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-11-29 EP disclosed
WO-1999041240-A1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-08-19 WO disclosed